Article analysis
Skim this article about "Why the Right Still Embraces Ivermectin": 3 key takeaways and more.
Why the Right Still Embraces Ivermectin
skim AI Analysis | New York Times
New York Times on Why the Right Still Embraces Ivermectin: skim's analysis surfaces 3 key takeaways. Interest in ivermectin is rising again, particularly among American conservatives, despite warnings from federal health officials about its limited medical benefits. Read the takeaways in seconds, then decide whether the full article is worth your time.
Summary
Interest in ivermectin is rising again, particularly among American conservatives, despite warnings from federal health officials about its limited medical benefits. The drug has become a symbol of resistance to perceived elitist and corrupt systems, leading some states to consider legislation allowing its over-the-counter sale, even as experts warn of potential dangers and the FDA emphasizes its lack of approval for treating COVID-19.
Key Takeaways
- Ivermectin's popularity is resurging among American conservatives, fueled by right-wing influencers despite warnings from health officials.
- The drug has become a symbol of resistance against perceived elitism and corruption within political, scientific, and medical establishments.
- Some states are considering legislation to allow over-the-counter sales of ivermectin, even as the FDA maintains it is not approved for treating COVID-19 and experts warn of potential overdoses.
Statement Breakdown
- Claimed Facts: 55% of statements the article presents as facts
- Opinions: 25% of statements classified as editorial or subjective
- Claims: 20% of statements surfaced for additional reader evaluation
Credibility & Bias Reasoning
Credibility assessment: The article cites multiple sources, including government health agencies, medical experts, and a law professor. It presents factual information regarding ivermectin's uses and the FDA's stance. The inclusion of perspectives from both proponents and opponents of ivermectin enhances credibility. However, the article also relies on anecdotal evidence and reports of individual experiences, which slightly reduces the overall credibility score. The publication in the New York Times lends some credibility, but the potential for bias must be considered.
Bias assessment: Moderate Left. The article leans slightly left due to its emphasis on the dangers of ivermectin and the warnings from health officials. While it mentions conservative support for the drug, it frames it as resistance to an 'elitist and corrupt cabal,' potentially casting conservatives in a negative light. The framing of ivermectin as a 'pharmacological MAGA hat' suggests a negative bias toward the conservative movement. While presenting information from multiple viewpoints, the overall tone is skeptical of ivermectin's benefits and critical of those who promote it.
Claimed Facts (7)
- States a verifiable fact about the drug's approved uses and its increased usage during the pandemic.
- Reports a specific legal action taken by a state governor.
- Reports a specific legal action taken by a state.
- States the official position of the FDA.
- Describes the content of right-wing media.
- Reports on a specific instance of advertising on a website.
- Lists known medical risks of using the drug.
Opinions (5)
- Expresses a personal belief about the motivations of politicians.
- This statement is an interpretation and assignment of symbolic meaning, reflecting the author's opinion.
- Expresses a personal preference and rationale based on distrust.
- Expresses concern, which is a subjective opinion.
- Expresses an opinion based on his study of history.
Claims (5)
- This is a nonsensical statement with no basis in fact.
- This statement makes unsubstantiated implications about someone embracing a questionable belief.
- These are unsubstantiated claims of medical cures attributed to ivermectin.
- Implies a potentially dangerous practice of using veterinary-grade medicine, based on anecdotal evidence.
- Suggests that consuming medication in this way is normal when there are approved delivery methods, despite the potential for dangerous side effects.
This analysis was generated by skim (skim.plus), an AI-powered content analysis platform by Credible AI. Scores and classifications represent the platform's AI-generated assessment and should be considered alongside other sources.
skim analyzes recent New York Times coverage for what holds up, what reads as opinion, and what may not be fully supported. Last updated 18th March 2026.